The Ministry of Health of Kazakhstan revealed the strain of the coronavirus “Delta” (“Indian” strain) in samples taken in all regions of the country. This was announced on Friday an interdepartmental commission to prevent the proliferation of coronavirus under the Government of the Republic.
“In connection with the distribution of Delta -Stamma in the world, the Ministry of Health conducted a PCR screening of positive laboratory samples obtained from infected coronavirus infection. On July 1, a PCR screening was conducted 414 samples to identify the Indian strain. According to results in 48, 3% detected Indian strain in all areas and cities of Nur-Sultan, Alma-Ata, Shymkent, “- quotes TASS message.
Final confirmation of the presence of mutation and its belonging to the strain “Delta” will be determined after the completion of full-hegeneous sequencing of DNA samples.
“The characteristics of the” Delta “clinic – the stamma is to reduce the incubation period up to five days, the intestinal symptoms, the rapid progression of the disease, an increase in the number of more young people, is a more severe course among children and pregnant women,” explained in the Interdepartmental Commission, Noting that the only way to protect against infection is vaccination.
In Kazakhstan, February 1 began to vaccinate the population from the coronavirus “satellite V” produced in Russia. At the end of February, shipment began to the regions of the country of the Russian vaccine, issued on the basis of the Karaganda pharmaceutical complex. From April 26, vaccination has begun to the local drug from Coronavirus Qazvac. At the end of April, the National Welfare Fund “Samruk-Kazyna” purchased 1 million doses of the Hayat-VAX vaccine of the Chinese company SINOPHARM. In addition, in early June, the first party of the Coronavac vaccine production of the Chinese company Sinovac Biotech in the amount of 500 thousand doses was received.